Logo image of MET

METLIFE INC (MET) Stock Fundamental Analysis

USA - NYSE:MET - US59156R1086 - Common Stock

77.58 USD
+0.4 (+0.52%)
Last: 11/11/2025, 2:19:09 PM
Fundamental Rating

4

MET gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 146 industry peers in the Insurance industry. Both the profitability and financial health of MET have multiple concerns. MET has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MET had positive earnings in the past year.
In the past year MET had a positive cash flow from operations.
Each year in the past 5 years MET has been profitable.
Each year in the past 5 years MET had a positive operating cash flow.
MET Yearly Net Income VS EBIT VS OCF VS FCFMET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

1.2 Ratios

With a Return On Assets value of 0.58%, MET is not doing good in the industry: 65.75% of the companies in the same industry are doing better.
MET's Return On Equity of 14.78% is fine compared to the rest of the industry. MET outperforms 71.23% of its industry peers.
MET has a Return On Invested Capital of 0.74%. This is in the lower half of the industry: MET underperforms 63.70% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MET is below the industry average of 4.51%.
The 3 year average ROIC (0.52%) for MET is below the current ROIC(0.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.58%
ROE 14.78%
ROIC 0.74%
ROA(3y)0.39%
ROA(5y)0.53%
ROE(3y)9.29%
ROE(5y)8.85%
ROIC(3y)0.52%
ROIC(5y)0.65%
MET Yearly ROA, ROE, ROICMET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 5.60%, MET is doing worse than 60.96% of the companies in the same industry.
MET's Profit Margin has declined in the last couple of years.
MET's Operating Margin of 9.33% is on the low side compared to the rest of the industry. MET is outperformed by 61.64% of its industry peers.
MET's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.33%
PM (TTM) 5.6%
GM N/A
OM growth 3Y-9.41%
OM growth 5Y-3.49%
PM growth 3Y-12.69%
PM growth 5Y-6.22%
GM growth 3YN/A
GM growth 5YN/A
MET Yearly Profit, Operating, Gross MarginsMET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

3

2. Health

2.1 Basic Checks

MET has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MET has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MET has been reduced compared to 5 years ago.
MET has a worse debt/assets ratio than last year.
MET Yearly Shares OutstandingMET Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MET Yearly Total Debt VS Total AssetsMET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

MET has a debt to FCF ratio of 1.31. This is a very positive value and a sign of high solvency as it would only need 1.31 years to pay back of all of its debts.
The Debt to FCF ratio of MET (1.31) is better than 65.07% of its industry peers.
MET has a Debt/Equity ratio of 0.72. This is a neutral value indicating MET is somewhat dependend on debt financing.
The Debt to Equity ratio of MET (0.72) is worse than 85.62% of its industry peers.
Even though the debt/equity ratio score it not favorable for MET, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 1.31
Altman-Z N/A
ROIC/WACC0.1
WACC7.54%
MET Yearly LT Debt VS Equity VS FCFMET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MET Yearly Current Assets VS Current LiabilitesMET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

MET shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.51%.
MET shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.91% yearly.
The Revenue has been growing slightly by 0.77% in the past year.
The Revenue has been growing slightly by 0.37% on average over the past years.
EPS 1Y (TTM)5.51%
EPS 3Y-3.75%
EPS 5Y5.91%
EPS Q2Q%21.54%
Revenue 1Y (TTM)0.77%
Revenue growth 3Y-0.02%
Revenue growth 5Y0.37%
Sales Q2Q%1.63%

3.2 Future

MET is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.71% yearly.
Based on estimates for the next years, MET will show a small growth in Revenue. The Revenue will grow by 4.29% on average per year.
EPS Next Y7.91%
EPS Next 2Y12.02%
EPS Next 3Y11.88%
EPS Next 5Y11.71%
Revenue Next Year2.94%
Revenue Next 2Y3.4%
Revenue Next 3Y3.79%
Revenue Next 5Y4.29%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MET Yearly Revenue VS EstimatesMET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
MET Yearly EPS VS EstimatesMET Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.20 indicates a reasonable valuation of MET.
Compared to the rest of the industry, the Price/Earnings ratio of MET indicates a somewhat cheap valuation: MET is cheaper than 64.38% of the companies listed in the same industry.
MET's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.28.
The Price/Forward Earnings ratio is 7.60, which indicates a rather cheap valuation of MET.
MET's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MET is cheaper than 71.92% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 33.61, MET is valued rather cheaply.
Industry RankSector Rank
PE 9.2
Fwd PE 7.6
MET Price Earnings VS Forward Price EarningsMET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

MET's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MET is cheaper than 70.55% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MET is valued a bit cheaper than the industry average as 78.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.39
EV/EBITDA 6.46
MET Per share dataMET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

MET's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.16
PEG (5Y)1.56
EPS Next 2Y12.02%
EPS Next 3Y11.88%

5

5. Dividend

5.1 Amount

MET has a Yearly Dividend Yield of 2.98%. Purely for dividend investing, there may be better candidates out there.
MET's Dividend Yield is a higher than the industry average which is at 3.45.
Compared to an average S&P500 Dividend Yield of 2.36, MET pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.98%

5.2 History

The dividend of MET has a limited annual growth rate of 4.59%.
MET has paid a dividend for at least 10 years, which is a reliable track record.
MET has decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.59%
Div Incr Years2
Div Non Decr Years2
MET Yearly Dividends per shareMET Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

41.87% of the earnings are spent on dividend by MET. This is a bit on the high side, but may be sustainable.
MET's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.87%
EPS Next 2Y12.02%
EPS Next 3Y11.88%
MET Yearly Income VS Free CF VS DividendMET Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B
MET Dividend Payout.MET Dividend Payout, showing the Payout Ratio.MET Dividend Payout.PayoutRetained Earnings

METLIFE INC

NYSE:MET (11/11/2025, 2:19:09 PM)

77.58

+0.4 (+0.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners91.3%
Inst Owner Change0.54%
Ins Owners0.17%
Ins Owner Change-0.09%
Market Cap51.59B
Revenue(TTM)71.94B
Net Income(TTM)4.09B
Analysts80
Price Target96.75 (24.71%)
Short Float %1.43%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 2.98%
Yearly Dividend2.43
Dividend Growth(5Y)4.59%
DP41.87%
Div Incr Years2
Div Non Decr Years2
Ex-Date11-04 2025-11-04 (0.5675)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.86%
Min EPS beat(2)-6.87%
Max EPS beat(2)-2.86%
EPS beat(4)0
Avg EPS beat(4)-5.61%
Min EPS beat(4)-10.99%
Max EPS beat(4)-1.74%
EPS beat(8)2
Avg EPS beat(8)-1.81%
EPS beat(12)4
Avg EPS beat(12)-2.85%
EPS beat(16)8
Avg EPS beat(16)6.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-4.27%
Max Revenue beat(2)2.63%
Revenue beat(4)2
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-6.53%
Max Revenue beat(4)2.63%
Revenue beat(8)4
Avg Revenue beat(8)-1.35%
Revenue beat(12)6
Avg Revenue beat(12)-0.87%
Revenue beat(16)7
Avg Revenue beat(16)-1.46%
PT rev (1m)1.49%
PT rev (3m)-1.02%
EPS NQ rev (1m)0.91%
EPS NQ rev (3m)-1.91%
EPS NY rev (1m)0.51%
EPS NY rev (3m)-2.85%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)0.73%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE 9.2
Fwd PE 7.6
P/S 0.71
P/FCF 3.39
P/OCF 3.39
P/B 1.86
P/tB 2.78
EV/EBITDA 6.46
EPS(TTM)8.43
EY10.87%
EPS(NY)10.21
Fwd EY13.17%
FCF(TTM)22.9
FCFY29.52%
OCF(TTM)22.9
OCFY29.52%
SpS109.89
BVpS41.63
TBVpS27.88
PEG (NY)1.16
PEG (5Y)1.56
Graham Number88.86
Profitability
Industry RankSector Rank
ROA 0.58%
ROE 14.78%
ROCE 0.97%
ROIC 0.74%
ROICexc 0.77%
ROICexgc 1.12%
OM 9.33%
PM (TTM) 5.6%
GM N/A
FCFM 20.84%
ROA(3y)0.39%
ROA(5y)0.53%
ROE(3y)9.29%
ROE(5y)8.85%
ROIC(3y)0.52%
ROIC(5y)0.65%
ROICexc(3y)0.53%
ROICexc(5y)0.66%
ROICexgc(3y)0.78%
ROICexgc(5y)0.97%
ROCE(3y)0.68%
ROCE(5y)0.84%
ROICexgc growth 3Y-6.12%
ROICexgc growth 5Y-2.06%
ROICexc growth 3Y-5.87%
ROICexc growth 5Y-1.33%
OM growth 3Y-9.41%
OM growth 5Y-3.49%
PM growth 3Y-12.69%
PM growth 5Y-6.22%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 1.31
Debt/EBITDA 2.64
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 6.7
Cash Conversion 202.22%
Profit Quality 372.26%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC7.54%
ROIC/WACC0.1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)633.54%
Profit Quality(5y)464.62%
High Growth Momentum
Growth
EPS 1Y (TTM)5.51%
EPS 3Y-3.75%
EPS 5Y5.91%
EPS Q2Q%21.54%
EPS Next Y7.91%
EPS Next 2Y12.02%
EPS Next 3Y11.88%
EPS Next 5Y11.71%
Revenue 1Y (TTM)0.77%
Revenue growth 3Y-0.02%
Revenue growth 5Y0.37%
Sales Q2Q%1.63%
Revenue Next Year2.94%
Revenue Next 2Y3.4%
Revenue Next 3Y3.79%
Revenue Next 5Y4.29%
EBIT growth 1Y42.7%
EBIT growth 3Y-9.43%
EBIT growth 5Y-3.13%
EBIT Next Year17.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.98%
FCF growth 3Y5.04%
FCF growth 5Y1.15%
OCF growth 1Y29.98%
OCF growth 3Y5.04%
OCF growth 5Y1.15%

METLIFE INC / MET FAQ

What is the fundamental rating for MET stock?

ChartMill assigns a fundamental rating of 4 / 10 to MET.


What is the valuation status of METLIFE INC (MET) stock?

ChartMill assigns a valuation rating of 6 / 10 to METLIFE INC (MET). This can be considered as Fairly Valued.


What is the profitability of MET stock?

METLIFE INC (MET) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for MET stock?

The Earnings per Share (EPS) of METLIFE INC (MET) is expected to grow by 7.91% in the next year.


How sustainable is the dividend of METLIFE INC (MET) stock?

The dividend rating of METLIFE INC (MET) is 5 / 10 and the dividend payout ratio is 41.87%.